These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1099 related articles for article (PubMed ID: 19202514)
1. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS. Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514 [TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions. Han YL; Zhang J; Li Y; Wang SL; Jing QM; Yi XH; Ma YY; Luan B; Wang G; Wang B Chin Med J (Engl); 2009 Mar; 122(6):643-7. PubMed ID: 19323927 [TBL] [Abstract][Full Text] [Related]
3. Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry. Tamburino C; Di Salvo ME; Capodanno D; Marzocchi A; Sheiban I; Margheri M; Maresta A; Barlocco F; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Patti A; De Servi S Eur Heart J; 2009 May; 30(10):1171-9. PubMed ID: 19276194 [TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry. Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993 [TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of drug-eluting stent implantation for patients with multiple coronary chronic total occlusions. Zhang J; Han YL; Li Y; Wang SL; Jing QM; Wang XZ; Ma YY; Luan B; Wang G; Wang B Chin Med J (Engl); 2010 Apr; 123(7):789-93. PubMed ID: 20497665 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study). Harjai KJ; Orshaw P; Shenoy C; Acharji S; Sporn D; Aboufares A; Stapleton D J Interv Cardiol; 2008 Aug; 21(4):315-24. PubMed ID: 18754967 [TBL] [Abstract][Full Text] [Related]
7. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry. Yan BP; Ajani AE; New G; Duffy SJ; Farouque O; Shaw J; Sebastian M; Lew R; Brennan A; Andrianopoulos N; Reid C; Clark DJ; Int J Cardiol; 2008 Nov; 130(3):374-9. PubMed ID: 18706719 [TBL] [Abstract][Full Text] [Related]
8. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes. Tamburino C; Di Salvo ME; Capodanno D; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S Am J Cardiol; 2009 Jan; 103(2):187-93. PubMed ID: 19121434 [TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry. Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467 [TBL] [Abstract][Full Text] [Related]
10. Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry. Capodanno D; Di Salvo ME; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S; Tamburino C Catheter Cardiovasc Interv; 2009 Feb; 73(3):310-6. PubMed ID: 19214964 [TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents. Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841 [TBL] [Abstract][Full Text] [Related]
12. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences. Cholteesupachai J; Udayachalerm W; Srimahachota S; Buddhari W; Chaipromprasit J; Songmuang SB; Suithichaiyakul T J Med Assoc Thai; 2009 Jun; 92(6):755-60. PubMed ID: 19530580 [TBL] [Abstract][Full Text] [Related]
13. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts. Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143 [TBL] [Abstract][Full Text] [Related]
14. Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowings. Harjai KJ; Orshaw P; Boura J; Sporn D Am J Cardiol; 2009 Jun; 103(11):1537-45. PubMed ID: 19463512 [TBL] [Abstract][Full Text] [Related]
15. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508 [TBL] [Abstract][Full Text] [Related]
16. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents. Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ; Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506 [TBL] [Abstract][Full Text] [Related]
17. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. Das P; Moliterno DJ; Charnigo R; Mukherjee D; Steinhubl SR; Sneed JD; Booth DC; Ziada KM J Invasive Cardiol; 2006 Sep; 18(9):405-8. PubMed ID: 16954577 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent. Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201 [TBL] [Abstract][Full Text] [Related]
19. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. Meliga E; Garcia-Garcia HM; Valgimigli M; Chieffo A; Biondi-Zoccai G; Maree AO; Cook S; Reardon L; Moretti C; De Servi S; Palacios IF; Windecker S; Colombo A; van Domburg R; Sheiban I; Serruys PW; J Am Coll Cardiol; 2008 Jun; 51(23):2212-9. PubMed ID: 18534266 [TBL] [Abstract][Full Text] [Related]